- Gilead Sciences, Inc.: Still In The Lead Or Lagging Behind? $GILD http://seekingalpha.com/article/2987036-gilead-sciences-inc-still-in-the-lead-or-lagging-behind-an-algorithmic-perspective?app=1&auth_param=e6uak:1afstii:ba5663281ebf6f05b8cde0ea6cbe2c1a&uprof=25 4 comments wallstreetbets
- Gilead CEO Becomes Billionaire on $84,000 Hepatitis Drug - John C. Martin, the chief executive officer of Gilead Sciences Inc. (GILD), has become a billionaire on the prospects of a powerful new hepatitis C drug that’s attracting scrutiny from payers and activists over its $1,000 per pill price tag http://www.bloomberg.com/news/2014-03-03/gilead-ceo-becomes-billionaire-on-84-000-hepatitis-drug.html 11 comments business